A mononuclear nonheme iron complex with higher affinity for O<sub>2</sub> than CO via hydrogen bonding.

Jux, Matthias; Mebs, Stefan; Haumann, Michael; Katz, Sagie; Garcia-Serres, Ricardo; Hildebrandt, Peter; Wang, Yong; Nam, Wonwoo et al. · Nat Commun · 2026

basic_science · Level V

Where this comes from

Abstract

Dioxygen activation at iron centers is central to many biological and synthetic oxidation processes. In proteins, the reactivity and stability of iron-dioxygen intermediates are often controlled by secondary-sphere interactions such as hydrogen bonding. For example, hemoglobin stabilizes a Fe-O<sub>2</sub> adduct through distal hydrogen bonding, while hemerythrin employs hydrogen bonding to stabilize reduced oxygen species within a diiron active site, enabling reversible O<sub>2</sub> binding. Here we show that a mononuclear nonheme iron complex, [Fe<sup>II</sup>(DIG<sub>3</sub>tren)]<sup>2+</sup> (DIG<sub>3</sub>tren = tris(N',N"-diisopropylguanidinyl-2-ethyl)amine), reversibly reduces O<sub>2</sub> by two electrons to generate an iron(IV)-peroxido species. Strong hydrogen bonds from N - H groups of the ligand stabilize the O<sub>2</sub><sup>2-</sup> ligand, while the electron-rich guanidine donors promote the unusual Fe<sup>II</sup>-mediated two-electron reduction of O<sub>2</sub>. As a result, the complex exhibits higher affinity for O<sub>2</sub> than for CO due to preferential hydrogen-bond stabilization of the peroxido intermediate. These results demonstrate how secondary-sphere design can control both O<sub>2</sub> activation and ligand selectivity at iron centers.